Johnson & Johnson Initiates 5-Year Safety Study for Mentor Breast Implants in China
Johnson & Johnson is conducting a 5-year observational study to evaluate the long-term safety of Mentor breast implants in the Chinese population.
Company
Pharmaceutical intelligence for Johnson & Johnson with 7 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No signals indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.